Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
出版年份 2021 全文链接
标题
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
作者
关键词
-
出版物
LANCET
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-05-16
DOI
10.1016/s0140-6736(21)00763-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Health Status Changes and Outcomes in Patients With Heart Failure and Mitral Regurgitation
- (2020) Suzanne V. Arnold et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Study Design and Rationale of EXPLORER-HCM
- (2020) Carolyn Y. Ho et al. Circulation-Heart Failure
- Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2020) Iacopo Olivotto et al. LANCET
- Mavacamten: treatment aspirations in hypertrophic cardiomyopathy
- (2020) Michael Papadakis et al. LANCET
- Guidelines on the Verge of a More Evidence-Based Era for Hypertrophic Cardiomyopathy
- (2020) Carolyn Y. Ho CIRCULATION
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
- (2020) John R. Teerlink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial
- (2019) Mikhail N. Kosiborod et al. CIRCULATION
- Medical Therapy for Heart Failure With Reduced Ejection Fraction
- (2018) Stephen J. Greene et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical Course and Management of Hypertrophic Cardiomyopathy
- (2018) Barry J. Maron NEW ENGLAND JOURNAL OF MEDICINE
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
- (2018) Mathew S. Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection Fraction
- (2017) Yashashwi Pokharel et al. JAMA Cardiology
- Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy
- (2016) Silvia Fortunato de Cano et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Quantifying clinical change: discrepancies between patients’ and providers’ perspectives
- (2016) Rachel P. Dreyer et al. QUALITY OF LIFE RESEARCH
- A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
- (2016) E. M. Green et al. SCIENCE
- 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
- (2014) EUROPEAN HEART JOURNAL
- Health-Related Quality of Life After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients With Severe Aortic Stenosis
- (2012) Matthew R. Reynolds et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy
- (2012) Christopher M. Huff et al. QUALITY OF LIFE RESEARCH
- Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure
- (2011) Kathryn E. Flynn et al. AMERICAN HEART JOURNAL
- Patient Health Status and Costs in Heart Failure
- (2009) Paul S. Chan et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More